Verastem Statistics
Total Valuation
Verastem has a market cap or net worth of $516.47 million. The enterprise value is $410.51 million.
Important Dates
The last earnings date was Wednesday, March 4, 2026, after market close.
| Earnings Date | Mar 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Verastem has 87.84 million shares outstanding. The number of shares has increased by 94.07% in one year.
| Current Share Class | 87.84M |
| Shares Outstanding | 87.84M |
| Shares Change (YoY) | +94.07% |
| Shares Change (QoQ) | +18.53% |
| Owned by Insiders (%) | 0.52% |
| Owned by Institutions (%) | 77.51% |
| Float | 75.06M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 17.09 |
| Forward PS | 4.78 |
| PB Ratio | 8.41 |
| P/TBV Ratio | 12.96 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 13.28 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.09, with a Debt / Equity ratio of 1.52.
| Current Ratio | 3.09 |
| Quick Ratio | 2.96 |
| Debt / Equity | 1.52 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -149.50 |
Financial Efficiency
Return on equity (ROE) is -1,480.15% and return on invested capital (ROIC) is -134.83%.
| Return on Equity (ROE) | -1,480.15% |
| Return on Assets (ROA) | -61.11% |
| Return on Invested Capital (ROIC) | -134.83% |
| Return on Capital Employed (ROCE) | -97.68% |
| Weighted Average Cost of Capital (WACC) | 5.66% |
| Revenue Per Employee | $303,078 |
| Profits Per Employee | -$2.05M |
| Employee Count | 102 |
| Asset Turnover | 0.18 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -15.80% in the last 52 weeks. The beta is 0.39, so Verastem's price volatility has been lower than the market average.
| Beta (5Y) | 0.39 |
| 52-Week Price Change | -15.80% |
| 50-Day Moving Average | 6.44 |
| 200-Day Moving Average | 7.46 |
| Relative Strength Index (RSI) | 46.46 |
| Average Volume (20 Days) | 1,484,446 |
Short Selling Information
The latest short interest is 17.10 million, so 19.46% of the outstanding shares have been sold short.
| Short Interest | 17.10M |
| Short Previous Month | 18.05M |
| Short % of Shares Out | 19.46% |
| Short % of Float | 22.78% |
| Short Ratio (days to cover) | 10.54 |
Income Statement
In the last 12 months, Verastem had revenue of $30.91 million and -$209.47 million in losses. Loss per share was -$3.02.
| Revenue | 30.91M |
| Gross Profit | 26.31M |
| Operating Income | -170.13M |
| Pretax Income | -209.47M |
| Net Income | -209.47M |
| EBITDA | -169.40M |
| EBIT | -170.13M |
| Loss Per Share | -$3.02 |
Full Income StatementBalance Sheet
The company has $204.99 million in cash and $87.17 million in debt, with a net cash position of $117.82 million or $1.34 per share.
| Cash & Cash Equivalents | 204.99M |
| Total Debt | 87.17M |
| Net Cash | 117.82M |
| Net Cash Per Share | $1.34 |
| Equity (Book Value) | 57.20M |
| Book Value Per Share | 0.74 |
| Working Capital | 151.15M |
Full Balance SheetCash Flow
| Operating Cash Flow | -137.51M |
| Capital Expenditures | n/a |
| Free Cash Flow | -137.51M |
| FCF Per Share | -$1.57 |
Full Cash Flow StatementMargins
| Gross Margin | 85.12% |
| Operating Margin | -550.33% |
| Pretax Margin | -677.59% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Verastem does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -94.07% |
| Shareholder Yield | -94.07% |
| Earnings Yield | -39.65% |
| FCF Yield | -26.03% |
Analyst Forecast
The average price target for Verastem is $15.00, which is 155.10% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $15.00 |
| Price Target Difference | 155.10% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (5Y) | 81.32% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 1, 2023. It was a reverse split with a ratio of 1:12.
| Last Split Date | Jun 1, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:12 |
Scores
Verastem has an Altman Z-Score of -6.69 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -6.69 |
| Piotroski F-Score | 3 |
